Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMixed Topics
Low-dose erlotinib seems feasible for frail, elderly patients with NSCLCMay 26, 2020Lung CancerOncology
FDA approves olaparib for certain metastatic prostate cancersMay 21, 2020Genitourinary CancerProstate CancerOncology
First PARP inhibitor approved for metastatic prostate cancerMay 19, 2020Genitourinary CancerProstate CancerOncology
Secondary acute lymphoblastic leukemia more lethal than de novoMay 14, 2020HematologyOncologyLeukemia, Myelodysplasia, Transplantation
ASCO goes ahead online, as conference center is used as hospitalMay 11, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
FDA approves selpercatinib for lung and thyroid RET tumorsMay 11, 2020Lung CancerHead & Neck/Thyroid Cancers
Vaccine maintenance improves relapse-free survival in BRCA wild-type ovarian cancerMay 6, 2020Oncology
